Latest filing published 05 Apr 2021 for Cidara Therapeutics, Inc., €4,822.
Filing timeline
BuySaleInsider track record
Neil Abdollahian: trading record in brief
Neil Abdollahian appears in our data through filings on Cidara Therapeutics, Inc. shares, published by SEC (Form 4). Between 18 September 2017 and 1 April 2021, the trades on record add up to 11 filings.
No open-market purchase appears, only 6 sales worth €36k. The rest of the record consists of 5 share grants. So far in 2021, the count stands at no purchases and 2 sales.
The record was last updated on 5 April 2021 with a share grant in Cidara Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Neil Abdollahian
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,868 shares@ US$2.0613.3% of flowCommon StockSEC:0001610618-21-000032:0
- 1,469 shares@ US$2.669.1% of flowCommon StockSEC:0001610618-21-000032:2
- 3,500 shares0Common StockSEC:0001610618-21-000032:1
- 940 shares@ US$3.4212.4% of flowCommon StockSEC:0001209191-20-039025:0
- 2,340 shares@ US$3.4225.4% of flowCommon StockSEC:0001209191-20-002034:0
- 7,284 shares@ US$1.9846.7% of flowCommon StockSEC:0001209191-19-052479:0
- 17,500 shares0Common StockSEC:0001209191-19-049681:0
- 4,900 shares0Common StockSEC:0001209191-19-049681:1
- 2,300 shares@ US$2.4417.7% of flowCommon StockSEC:0001209191-19-018294:0
- 6,000 shares0Common StockSEC:0001209191-19-006613:0
- 15,000 shares0Common StockSEC:0001209191-17-053312:0
11 of 11 declarations
